Search Results

There are 5070 results for: content related to: Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation

  1. Is Once-Daily Mesalazine Equivalent to the Currently Used Twice-Daily Regimen? A Study Performed in 30 Healthy Volunteers

    The Journal of Clinical Pharmacology

    Volume 47, Issue 3, March 2007, Pages: 334–342, Dr Peggy Gandia, Dr Isabelle Idier and Dr Georges Houin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270006296522

  2. You have free access to this content
    Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis – a pooled analysis

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 9, November 2011, Pages: 1115–1122, L. Leifeld, R. Pfützer, J. Morgenstern, P. R. Gibson, Y. Marakhouski, R. Greinwald, R. Mueller and W. Kruis

    Version of Record online : 19 SEP 2011, DOI: 10.1111/j.1365-2036.2011.04840.x

  3. Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 5, September 2004, Pages: 626–631, Heleen Wiersma, Johanna C. Escher, Karin Dilger, Dietmar Trenk, Marc A. Benninga, Chris J. van Boxtel and Jan Taminiau

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200409000-00019

  4. You have free access to this content
    Systematic review: the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 7, April 2006, Pages: 841–855, R. BERGMAN and M. PARKES

    Version of Record online : 17 MAR 2006, DOI: 10.1111/j.1365-2036.2006.02846.x

  5. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Yongjun Wang, Claire E Parker, Tania Bhanji, Brian G Feagan and John K MacDonald

    Published Online : 21 APR 2016, DOI: 10.1002/14651858.CD000543.pub4

  6. You have free access to this content
    Systematic review: the potential influence of mesalazine formulation on maintenance of remission in Crohn’s disease

    Alimentary Pharmacology & Therapeutics

    Volume 25, Issue 12, June 2007, Pages: 1389–1399, A. H. STEINHART, A. FORBES, E. C. MILLS, B. S. RODGERS-GRAY and S. P. L. TRAVIS

    Version of Record online : 30 MAR 2007, DOI: 10.1111/j.1365-2036.2007.03324.x

  7. You have free access to this content
    The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 357–361, STØA-BIRKETVEDT and FLORHOLMEN

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00483.x

  8. You have free access to this content
    MMX Multi Matrix System® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 2, July 2007, Pages: 205–215, W. J. SANDBORN, M. A. KAMM, G. R. LICHTENSTEIN, A. LYNE, T. BUTLER and R. E. JOSEPH

    Version of Record online : 4 MAY 2007, DOI: 10.1111/j.1365-2036.2007.03361.x

  9. You have free access to this content
    Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months

    Alimentary Pharmacology & Therapeutics

    Volume 12, Issue 12, December 1998, Pages: 1207–1216, Green, Gibson, Kerr, Swarbrick, Lobo, Holdsworth, Crowe, Schofield, Taylor and THE ABACUS INVESTIGATOR GROUP

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1365-2036.1998.00427.x

  10. You have free access to this content
    MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations

    Alimentary Pharmacology & Therapeutics

    Volume 27, Issue 11, June 2008, Pages: 1094–1102, G. R. LICHTENSTEIN, M. A. KAMM, W. J. SANDBORN, A. LYNE and R. E. JOSEPH

    Version of Record online : 22 MAR 2008, DOI: 10.1111/j.1365-2036.2008.03688.x

  11. You have free access to this content
    Short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 2, January 2004, Pages: 179–189, E. V. Loftus JR, S. V. Kane and D. Bjorkman

    Version of Record online : 14 JAN 2004, DOI: 10.1111/j.0269-2813.2004.01827.x

  12. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Yongjun Wang, Claire E Parker, Brian G Feagan and John K MacDonald

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD000544.pub4

  13. You have free access to this content
    Review article: increasing the dose of oral mesalazine therapy for active ulcerative colitis does not improve remission rates

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 9, November 2007, Pages: 1179–1186, A. V. SAFDI and R. D. COHEN

    Version of Record online : 20 AUG 2007, DOI: 10.1111/j.1365-2036.2007.03471.x

  14. You have full text access to this OnlineOpen article
    Maintaining stable symptom control in inflammatory bowel disease: a retrospective analysis of adherence, medication switches and the risk of relapse

    Alimentary Pharmacology & Therapeutics

    Volume 38, Issue 5, September 2013, Pages: 531–538, A. Robinson, M. Hankins, G. Wiseman and M. Jones

    Version of Record online : 8 JUL 2013, DOI: 10.1111/apt.12396

  15. You have free access to this content
    Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 7, October 2006, Pages: 1087–1097, G. D'HAENS, D. HOMMES, L. ENGELS, F. BAERT, L. VAN DER WAAIJ, P. CONNOR, J. RAMAGE, O. DEWIT, M. PALMEN, D. STEPHENSON and R. JOSEPH

    Version of Record online : 12 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03082.x

  16. You have free access to this content
    A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue 3, March 1999, Pages: 381–388, GIONCHETTI, ARDIZZONE, BENVENUTI, BIANCHI PORRO, BIASCO, CESARI, D'ALBASIO, DE FRANCHIS, MONTELEONE, PALLONE, RANZI, TRALLORI, VALPIANI, VECCHI and CAMPIERI

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00482.x

  17. You have free access to this content
    The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 28, Issue 11-12, December 2008, Pages: 1287–1296, A. BUCKLAND and K. BODGER

    Version of Record online : 19 SEP 2008, DOI: 10.1111/j.1365-2036.2008.03856.x

  18. You have free access to this content
    Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 1, January 2000, Pages: 1–6, Corrigan and Stevens

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00683.x

  19. You have free access to this content
    Evaluation of renal function following treatment with 5-aminosalicylic acid derivatives in patients with ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 2, February 2002, Pages: 207–215, N. Mahmud, D. O'Toole, N. O'Hare, P. J. Freyne, D. G. Weir and D. Kelleher

    Version of Record online : 18 JAN 2002, DOI: 10.1046/j.1365-2036.2002.01155.x

  20. You have free access to this content
    Review article: oral, modified-release mesalazine formulations — proprietary versus generic

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 10, 15th May 2003, Pages: 1207–1214, A. Forbes, A. Cartwright, S. Marchant, P. Mcintyre and M. Newton

    Version of Record online : 16 MAY 2003, DOI: 10.1046/j.1365-2036.2003.01578.x